Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Operating Margin: 2021-2024

Historic Operating Margin for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to -10.78%.

  • Kiniksa Pharmaceuticals International's Operating Margin rose 2189.00% to 13.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.38%, marking a year-over-year increase of 1321.00%. This contributed to the annual value of -10.78% for FY2024, which is 145.00% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Operating Margin stood at -10.78% for FY2024, which was down 15.61% from -9.32% recorded in FY2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Operating Margin peaked at 97.73% during FY2022, and registered a low of -406.38% during FY2021.
  • Moreover, its 3-year median value for Operating Margin was -9.32% (2023), whereas its average is 25.88%.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Operating Margin spiked by 50,411bps in 2022 and then slumped by 10,705bps in 2023.
  • Yearly analysis of 4 years shows Kiniksa Pharmaceuticals International's Operating Margin stood at -406.38% in 2021, then surged by 50,411bps to 97.73% in 2022, then plummeted by 10,705bps to -9.32% in 2023, then plummeted by 145bps to -10.78% in 2024.